1-4 of 4
Ahmad Halwani, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab Vedotin with RCHOP As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL): Results from an Ongoing Phase 2 Study

Christopher A. Yasenchak, MD, Ahmad Halwani, MD, Ranjana Advani, Stephen Ansell, MD PhD, Lihua Elizabeth Budde, MD PhD, John M. Burke, MD, Charles M. Farber, MD PhD, Beata Holkova, MD, Luis E. Fayad, MD, Kathryn S. Kolibaba, MD, Mark Knapp, MD, Martha Li, PhD, Thomas J. Manley, MD, Dipti Patel-Donnelly, MD, Mahesh Seetharam, MD, Habte A. Yimer, MD, Nancy L Bartlett, MD
Journal: Blood
Blood (2015) 126 (23): 814.
https://doi.org/10.1182/blood.V126.23.814.814
Published: 2015
Journal Articles

Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma - Preliminary Safety, Efficacy and Biomarker Results of a Phase I Study

Philippe Armand, MD PhD, Stephen M. Ansell, MD PhD, Alexander M. Lesokhin, MD, Ahmad Halwani, MD, Michael M. Millenson, MD, Stephen J. Schuster, MD, John Timmerman, MD, Ivan Borrello, MD, Martin Gutierrez, MD, Emma C. Scott, MD, Deepika Cattry, MSc, CCRP, Bjoern Chapuy, MD PhD, Azra H. Ligon, PhD, Scott J. Rodig, MD PhD, Lili Zhu, MSc, Joseph F. Grosso, PhD, Su Young Kim, MD PhD, Margaret A. Shipp, MD
Journal: Blood
Blood (2014) 124 (21): 289.
https://doi.org/10.1182/blood.V124.21.289.289
Published: 2014
Journal Articles

Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies

Alexander M. Lesokhin, MD, Stephen M. Ansell, MD PhD, Philippe Armand, MD PhD, Emma C. Scott, MD, Ahmad Halwani, MD, Martin Gutierrez, MD, Michael M. Millenson, MD, Adam D. Cohen, MD, Stephen J. Schuster, MD, Daniel Lebovic, Madhav V. Dhodapkar, MD, David Avigan, MD, Bjoern Chapuy, MD PhD, Azra H. Ligon, PhD, Scott J. Rodig, MD PhD, Deepika Cattry, MSc, CCRP, Lili Zhu, MSc, Joseph F. Grosso, PhD, Su Young Kim, MD PhD, Margaret A. Shipp, MD, Ivan Borrello, MD, John Timmerman, MD
Journal: Blood
Blood (2014) 124 (21): 291.
https://doi.org/10.1182/blood.V124.21.291.291
Published: 2014
Journal Articles

Brentuximab Vedotin in Combination with RCHOP As Front-Line Therapy in Patients with DLBCL: Interim Results from a Phase 2 Study

Christopher A. Yasenchak, MD, Charles M. Farber, MD PhD, Lihua Elizabeth Budde, MD, Stephen M. Ansell, MD PhD, Ranjana Advani, MD, Beata Holkova, MD, Ahmad Halwani, MD, Mark Knapp, MD, Luis Fayad, MD, Kathryn S. Kolibaba, MD, Dipti Patel-Donnelly, MD, Mahesh Seetharam, Thomas J. Manley, MD, Nancy L. Bartlett, MD
Journal: Blood
Blood (2014) 124 (21): 1745.
https://doi.org/10.1182/blood.V124.21.1745.1745
Published: 2014